| Literature DB >> 33003648 |
Kashaf Junaid1, Hasan Ejaz1, Abualgasim Elgaili Abdalla1,2, Khalid O A Abosalif1,2, Muhammad Ikram Ullah1, Humaira Yasmeen3, Sonia Younas4, Sanaa S M Hamam5,6, Abdul Rehman7.
Abstract
The third coronavirus outbreak in the last two decades has caused significant damage to the world's economy and community health. The highly contagious COVID-19 infection has affected millions of people to date and has led to hundreds of thousands of deaths worldwide. Aside from the highly infectious nature of SARS-CoV-2, the lack of a treatment or vaccine has been the main reason for its spread. Thus, it has become necessary to find alternative methods for controlling SARS-CoV-2. For the present review, we conducted an online search for different available nutrition-based therapies for previously known coronavirus infections and RNA-based virus infections as well as general antiviral therapies. These treatments have promise for combating COVID-19, as various nutrients and minerals play direct and indirect roles in the control and prevention of this newly emerged viral infection. The patients' nutritional status with COVID-19 must be analyzed before administering any treatment, and nutritional supplements should be given to the affected individuals along with routine treatment. We suggest a potential interventional role of nutrients to strengthen the immune system against the emerging infection caused by COVID-19.Entities:
Keywords: COVID-19; immune enhancement; immunonutrition; minerals; nutrients; public health; vitamins
Mesh:
Substances:
Year: 2020 PMID: 33003648 PMCID: PMC7599934 DOI: 10.3390/nu12102992
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Schematic representation of processes used by the host immune system to combat COVID-19. The antigen-presenting cells (dendritic cells and macrophages) present the virus to naïve Th cells and stimulate the adaptive immune system. T cells also signal monocytes and macrophages to attract them to the infection site, where they release chemokines. Toll-like receptors (TLR) present on antigen-presenting cells recognize specific receptors on the virus and secrete inflammatory markers in innate immune system response. Mast cells activated by the pathogen release proinflammatory markers, proteases, and histamines. The upregulated secretion of proinflammatory markers causes a cytokine storm. IL-1 = interleukin 1; IL-2 = interleukin 2; IL-12 = interleukin 12; IL-4 = interleukin 4; IL-5 = interleukin 5; IL-6 = interleukin 6; IL-10 = interleukin 10, IFN-γ = interferon gamma; TNF-α = tumor necrosis factor alpha; CTL = cytotoxic T lymphocytes; NK = natural killer; C3a = complement component 3a; and C5a = complement component 5a.
Examples of clinical trials on the use of vitamins against COVID-19 registered by the WHO [8].
| Trial ID | Study Design | Sample Size | Settings | Intervention in COVID-19 Patients |
|---|---|---|---|---|
| ChiCTR2000032400 | Cohort | 60 | China | High dose of vitamin C. |
| RCT20200401046909N1 | Randomized clinical trial | 260 | Iran | 1000 IUs of vitamin D daily for 8 weeks. |
| IRCT20180520039738N2 | Randomized clinical trial | 140 | Iran | Vitamin A (25,000 IU/day) for 10 days. |
| DRKS00021214 | Randomized clinical trial | 1300 | Germany | Vitamin B3 (nicotinamide) 1000 mg/day for 4 weeks. |
| EUCTR2020-001602-34-FR | Randomized clinical trial | 260 | France | A high dose of vitamin D (400,000 IU) versus a standard dose (50,000 IU) once daily for 14 days. |
| TCTR20200404004 | Randomized clinical trial | 400 | Thailand | Comparison of chloroquine, (10 mg base/kg) and vitamin C (1000 mg). |
| IRCT20170117032004N3 | Randomized clinical trial | 30 | Iran | Vitamin A (50,000 IU) along with routine treatment for 2 weeks. |
| CTRI/2020/06/026189 | Randomized clinical trial | 210 | India | Vitamin D (60,000 IU) single-dose and magnesium glycinate (250 mg bi-dose) for 14 days. |
| IRCT20200319046819N1 | Randomized clinical trial | 60 | Iran | Vitamin A (25,000 IU), Vitamin D (600,000 IU) once during the intervention, Vitamin E (300 IU) twice daily, Vitamin C (500 mg) five times a day, and Vitamin B (Soluvit ampoule) daily. |
| NCT04335084 | Randomized clinical trial | 600 | USA | Hydroxychloroquine, Vitamin C, D, and Zinc. |
| NCT04264533 | Randomized clinical trial | 140 | China | Vitamin C (12 g) twice a day for 7 days. |
IU, International units.
Figure 2Mechanism of action of micronutrients against CoVs. NK = natural killer; ACE-2 = angiotensin-converting enzyme 2.